NAD+ 1g & Tirzepatide - A UK News
The growing landscape of metabolic health in the UK is seeing increasing interest in the combination of high-dose Nicotinamide Adenine Dinucleotide supplementation – often at 1g dosage – and the novel GLP-1 receptor agonist Retatrutide (or its analogue Tirzepatide). Specialists are observing pote